Plain-English translation of NCT06832410 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new treatment called VX-880 to see if it can help people with type 1 diabetes who have received a kidney transplant. The treatment is designed to help your body produce insulin naturally and manage blood sugar more effectively. Researchers want to understand how safe and helpful this medication is for people in your situation.
People with type 1 diabetes need insulin injections or pumps every day to survive, which can be challenging and burdensome. This trial explores whether this new cell-based treatment could reduce or eliminate that need, giving patients a better quality of life.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive the VX-880 treatment as part of this carefully monitored study. You will need to visit the clinic for evaluations and continue wearing your continuous glucose monitor throughout the trial so researchers can track how well the treatment works and watch for any side effects. The study involves about 10 participants total, and your medical team will closely monitor your kidney transplant function and blood sugar control.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Canada